Wacker Expands Service Offerings with Launch of Contract Research for Nucleic Acid-Based Therapies
In addition to producing pDNA, RNA, and LNP formulations, Wacker’s CRS team offers construct design services, including plasmid and RNA construct design as well as RNA engineering and optimization via partners. The post Wacker Expands Service Offerings with Launch of Contract Research for Nucleic Acid-Based Therapies appeared first on GEN - Genetic Engineering and Biotechnology News.
Original Source
Read the full article at Genengnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.